Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Jensen, Donald
Item TypeName
Concept RNA, Viral
Academic Article Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1.
Academic Article Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C.
Academic Article Rationale and design of the REPEAT study: a phase III, randomized, clinical trial of peginterferon alfa-2a (40 kDa) plus ribavirin in non-responders to peginterferon alfa-2b (12 kDa) plus ribavirin.
Academic Article Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirin.
Academic Article Sustained viral response after interferon-based therapy in chronic hepatitis C: more evidence to support a life-long cure.
Academic Article Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial.
Academic Article Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients.
Academic Article Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents.
Academic Article The importance of rapid viral suppression in the era of directly acting antiviral therapy for hepatitis C virus.
Academic Article Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
Academic Article Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin.
Academic Article Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study.
Academic Article Faldaprevir, pegylated interferon, and ribavirin for treatment-na?ve HCV genotype-1: pooled analysis of two phase 3 trials.
Search Criteria
  • RNA Viral